If you've caught yourself thinking you're too young for a symptom to be worth raising – that whatever it is will almost certainly be stress, hormones or something that will pass – you're not the only one. It's also not the safe assumption it used to be. Cancer in people under 50 in the UK has been rising for three decades, and although it remains less common than cancer in the over-60s, the gap is narrower than it was.

The instinct to wait – to see if it clears or to give it another month – has been the reasonable default for most of a lifetime. Whether it still is, for a symptom that has been sitting in your body for weeks, is a different question now.

Cancer Under 50 Is More Common Than It Was

Cancer Research UK's analysis of UK incidence data puts the rise in 25- to 49-year-olds at 24% between 1995 and 2019, taking the rate from 132.9 per 100,000 people to 164.6. Around 35,000 people in that age bracket are diagnosed each year. Bowel cancer drives a large share of the shift – incidence in under-50s is up 22% across the same period, and England recorded one of the fastest rates of increase in early-onset bowel cancer of any country in Europe over the decade to 2017. Breast cancer diagnoses in women under 50 now top 10,000 a year; roughly one in five new breast cancer cases is in that age group.

None of this means cancer is suddenly common in your 30s. It means the baseline has moved, and the advice calibrated for a different baseline has moved with it more slowly.

Why Symptoms In Younger People Are Easier To Miss

GPs work to guidelines that were written against a risk profile in which under-50s accounted for a very small share of the caseload. A British Journal of General Practice qualitative study of GP referral decisions found that clinicians' threshold for suspecting cancer rises with patient age, because statistically the suspicion is more likely to pay off. A patient in their 60s with persistent fatigue triggers a workup. A patient in their 30s with the same presentation more often walks out with a blood test and a follow-up date.

The symptoms that tend to get attributed to something else are the ones that also have ordinary explanations: bloating that doesn't settle, a change in bowel habit lasting more than a few weeks, unexplained weight loss, a persistent ache in one place, bleeding between periods or after sex, or a lump or change in how a breast looks that doesn't come and go with the cycle. None of these mean cancer, but all of them are worth saying out loud.

What The Screening Programmes Do And Don't Cover

The NHS screening programmes were designed against the prevailing risk data at the time they were set up. Bowel screening runs from age 50 to 74, with an at-home test sent every two years. Breast screening runs from 50 up to a woman's 71st birthday, with invitations every three years. Cervical screening is the one exception – it runs from 25 to 64, because the clinical profile of cervical cancer warrants an earlier start.

Unless you're inside the cervical band, the NHS system doesn't have a regular way of checking you under 50. The expectation is that a symptom will bring you in. That works, mostly. It works less well when the symptom has a dozen ordinary explanations and the clinician's threshold for investigating it is higher than it would be for someone 20 years older.

What Faster Access To Answers Actually Changes

The difference between investigating a symptom at six weeks and investigating it at six months isn't cosmetic. Bowel cancer caught at stage 2 is, in practical terms, a different disease from bowel cancer caught at stage 3 – shorter treatment, less invasive surgery and markedly better five-year survival. The same applies across most solid tumours. The point of faster imaging is not to reassure the worried well, but to shorten the window in which a cancer, if there is one, is gaining ground.

The NHS has been moving in the right direction on this. The Faster Diagnosis Standard – the benchmark that 80% of people referred with suspected cancer should have a diagnosis confirmed or ruled out within 28 days – has been climbing, and the service is doing it under considerable volume pressure. The number still means, though, that a meaningful share of patients on an urgent pathway are waiting longer than 28 days. For a 36-year-old with a persistent symptom, the gap between suspected and confirmed is rarely the part of the process they want to stretch.

Where This Leaves You

The lifestyle case sits alongside the diagnostic one. The same research that documents the rise in early-onset cancer points to dietary patterns, obesity, sedentary behaviour and alcohol as contributors, though it hasn't yet settled how much of the rise is behavioural and how much is environmental. Active choices matter.

But preventative health starts, mostly, by not waiting. If a symptom has been sitting there for a few weeks and the obvious explanations are wearing thin, the risk calculus for raising it isn't what it was a generation ago. You're not being precious by asking – you're being current with the evidence.

If you'd like to raise it today, we can see you today.